Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.01
COO's Cash to Debt is ranked lower than
99% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. COO: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
COO' s 10-Year Cash to Debt Range
Min: 0  Med: 0.05 Max: 1.92
Current: 0.01
0
1.92
Equity to Asset 0.59
COO's Equity to Asset is ranked lower than
51% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. COO: 0.59 )
Ranked among companies with meaningful Equity to Asset only.
COO' s 10-Year Equity to Asset Range
Min: -0.02  Med: 0.58 Max: 0.8
Current: 0.59
-0.02
0.8
Interest Coverage 38.48
COO's Interest Coverage is ranked higher than
50% of the 105 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.02 vs. COO: 38.48 )
Ranked among companies with meaningful Interest Coverage only.
COO' s 10-Year Interest Coverage Range
Min: 1.07  Med: 6.18 Max: 38.48
Current: 38.48
1.07
38.48
F-Score: 3
Z-Score: 4.12
M-Score: -2.89
WACC vs ROIC
3.58%
7.42%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 15.73
COO's Operating margin (%) is ranked higher than
77% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.42 vs. COO: 15.73 )
Ranked among companies with meaningful Operating margin (%) only.
COO' s 10-Year Operating margin (%) Range
Min: 4.82  Med: 19.44 Max: 23.82
Current: 15.73
4.82
23.82
Net-margin (%) 13.52
COO's Net-margin (%) is ranked higher than
80% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.58 vs. COO: 13.52 )
Ranked among companies with meaningful Net-margin (%) only.
COO' s 10-Year Net-margin (%) Range
Min: -1.18  Med: 15.22 Max: 34.8
Current: 13.52
-1.18
34.8
ROE (%) 9.35
COO's ROE (%) is ranked higher than
60% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.05 vs. COO: 9.35 )
Ranked among companies with meaningful ROE (%) only.
COO' s 10-Year ROE (%) Range
Min: -0.79  Med: 12.88 Max: 244.12
Current: 9.35
-0.79
244.12
ROA (%) 6.09
COO's ROA (%) is ranked higher than
67% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. COO: 6.09 )
Ranked among companies with meaningful ROA (%) only.
COO' s 10-Year ROA (%) Range
Min: -0.45  Med: 8.92 Max: 22.6
Current: 6.09
-0.45
22.6
ROC (Joel Greenblatt) (%) 20.36
COO's ROC (Joel Greenblatt) (%) is ranked higher than
60% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.82 vs. COO: 20.36 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
COO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 5.39  Med: 29.04 Max: 82.32
Current: 20.36
5.39
82.32
Revenue Growth (3Y)(%) 8.40
COO's Revenue Growth (3Y)(%) is ranked higher than
70% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. COO: 8.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
COO' s 10-Year Revenue Growth (3Y)(%) Range
Min: 4.8  Med: 13.40 Max: 27.8
Current: 8.4
4.8
27.8
EBITDA Growth (3Y)(%) 12.30
COO's EBITDA Growth (3Y)(%) is ranked higher than
63% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. COO: 12.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
COO' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -8.6  Med: 17.20 Max: 62.2
Current: 12.3
-8.6
62.2
EPS Growth (3Y)(%) 14.90
COO's EPS Growth (3Y)(%) is ranked higher than
65% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. COO: 14.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
COO' s 10-Year EPS Growth (3Y)(%) Range
Min: -15.2  Med: 16.70 Max: 474.9
Current: 14.9
-15.2
474.9
» COO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

COO Guru Trades in Q3 2014

Paul Tudor Jones 5,800 sh (+20.83%)
Ken Fisher 56,294 sh (+13.48%)
Manning & Napier Advisors, Inc Sold Out
Steven Cohen Sold Out
Ron Baron 356,193 sh (-0.17%)
Chuck Royce 2,200 sh (-29.03%)
Mario Gabelli 27,200 sh (-45.15%)
» More
Q4 2014

COO Guru Trades in Q4 2014

Steve Mandel 1,750,283 sh (New)
Jim Simons 223,098 sh (New)
Mario Gabelli 34,500 sh (+26.84%)
Ken Fisher 68,524 sh (+21.73%)
Paul Tudor Jones Sold Out
Chuck Royce Sold Out
Ron Baron 355,785 sh (-0.11%)
» More
Q1 2015

COO Guru Trades in Q1 2015

Ken Fisher 72,657 sh (+6.03%)
Steve Mandel Sold Out
Ron Baron 352,815 sh (-0.83%)
Mario Gabelli 28,500 sh (-17.39%)
Jim Simons 112,298 sh (-49.66%)
» More
Q2 2015

COO Guru Trades in Q2 2015

Ken Fisher 78,332 sh (+7.81%)
» More
» Details

Insider Trades

Latest Guru Trades with COO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Cooper Companies

Baron Funds Comments on The Cooper Companies - May 02, 2014

We established a position in The Cooper Companies, Inc. (NYSE:COO) during the quarter. Cooper's primary business is manufacturing contact lenses, and it also has a relatively small unit focused on women's health products. There are several characteristics of the contact lens market that we find attractive. There are just four global players that account for the large bulk of the industry's sales, barriers to entry are high, and pricing trends are stable. The industry has grown at a mid-single digit rate for the past several years, and we believe that several developments should cause this growth rate to accelerate going forward. These include the widespread adoption of Silicon Hydrogel lenses, which provide a more comfortable user experience; recent technological advances that have led to lenses that can address a wider variety of vision deficiencies; the increasing conversion of bi-weekly contact users to daily-use lenses (which results in higher revenues for the manufacturer); and, the ongoing growth of the middle classes in emerging markets, which allows new entrants into the contact market.



Cooper is the third largest lens manufacturer with approximately 20% market share. The company has grown its share in recent years by introducing technologically superior products, particularly in the fast- growing Silicon Hydrogel market segment. We believe that Cooper can continue to grow at an above-market rate by further penetrating the global market with its superior products and by converting existing users from bi- weekly to daily contacts. In addition, we believe that Cooper should be able to expand its operating margins at a faster rate than revenues, as its Silicon Hydrogel lenses carry meaningfully higher gross margins than its legacy products, and sales growth will allow the company to leverage its fixed overheard. We believe Cooper will be able to grow its earnings per share at a high-teens rate for the next several years.



From Baron Funds' first quarter 2014 letter to investors.



Check out Ron Baron latest stock trades

Ratios

vs
industry
vs
history
P/E(ttm) 36.25
COO's P/E(ttm) is ranked lower than
58% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.20 vs. COO: 36.25 )
Ranked among companies with meaningful P/E(ttm) only.
COO' s 10-Year P/E(ttm) Range
Min: 7.98  Med: 22.31 Max: 1011.75
Current: 36.25
7.98
1011.75
Forward P/E 19.49
COO's Forward P/E is ranked higher than
65% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.03 vs. COO: 19.49 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 36.10
COO's PE(NRI) is ranked lower than
61% of the 110 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.60 vs. COO: 36.10 )
Ranked among companies with meaningful PE(NRI) only.
COO' s 10-Year PE(NRI) Range
Min: 8.11  Med: 22.32 Max: 2023.5
Current: 36.1
8.11
2023.5
P/B 3.31
COO's P/B is ranked lower than
54% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.85 vs. COO: 3.31 )
Ranked among companies with meaningful P/B only.
COO' s 10-Year P/B Range
Min: 0.37  Med: 1.81 Max: 4.46
Current: 3.31
0.37
4.46
P/S 4.90
COO's P/S is ranked lower than
65% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.84 vs. COO: 4.90 )
Ranked among companies with meaningful P/S only.
COO' s 10-Year P/S Range
Min: 0.51  Med: 2.83 Max: 5.98
Current: 4.9
0.51
5.98
PFCF 40.51
COO's PFCF is ranked lower than
65% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.29 vs. COO: 40.51 )
Ranked among companies with meaningful PFCF only.
COO' s 10-Year PFCF Range
Min: 7.34  Med: 26.48 Max: 342.65
Current: 40.51
7.34
342.65
POCF 19.39
COO's POCF is ranked higher than
52% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.15 vs. COO: 19.39 )
Ranked among companies with meaningful POCF only.
COO' s 10-Year POCF Range
Min: 5.51  Med: 14.51 Max: 27.33
Current: 19.39
5.51
27.33
EV-to-EBIT 36.01
COO's EV-to-EBIT is ranked lower than
78% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.59 vs. COO: 36.01 )
Ranked among companies with meaningful EV-to-EBIT only.
COO' s 10-Year EV-to-EBIT Range
Min: 8.2  Med: 19.30 Max: 68.2
Current: 36.01
8.2
68.2
PEG 2.84
COO's PEG is ranked higher than
54% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. COO: 2.84 )
Ranked among companies with meaningful PEG only.
COO' s 10-Year PEG Range
Min: 0.79  Med: 1.61 Max: 31.7
Current: 2.84
0.79
31.7
Shiller P/E 39.25
COO's Shiller P/E is ranked lower than
59% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.99 vs. COO: 39.25 )
Ranked among companies with meaningful Shiller P/E only.
COO' s 10-Year Shiller P/E Range
Min: 6.66  Med: 32.92 Max: 49.38
Current: 39.25
6.66
49.38
Current Ratio 1.49
COO's Current Ratio is ranked lower than
79% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. COO: 1.49 )
Ranked among companies with meaningful Current Ratio only.
COO' s 10-Year Current Ratio Range
Min: 0.98  Med: 2.13 Max: 3.46
Current: 1.49
0.98
3.46
Quick Ratio 0.74
COO's Quick Ratio is ranked lower than
89% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.63 vs. COO: 0.74 )
Ranked among companies with meaningful Quick Ratio only.
COO' s 10-Year Quick Ratio Range
Min: 0.69  Med: 1.21 Max: 2.95
Current: 0.74
0.69
2.95
Days Inventory 202.26
COO's Days Inventory is ranked lower than
78% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 129.36 vs. COO: 202.26 )
Ranked among companies with meaningful Days Inventory only.
COO' s 10-Year Days Inventory Range
Min: 162.06  Med: 200.94 Max: 231.4
Current: 202.26
162.06
231.4
Days Sales Outstanding 54.78
COO's Days Sales Outstanding is ranked higher than
61% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.83 vs. COO: 54.78 )
Ranked among companies with meaningful Days Sales Outstanding only.
COO' s 10-Year Days Sales Outstanding Range
Min: 52.77  Med: 61.36 Max: 119.83
Current: 54.78
52.77
119.83

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.03
COO's Dividend Yield is ranked lower than
100% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. COO: 0.03 )
Ranked among companies with meaningful Dividend Yield only.
COO' s 10-Year Dividend Yield Range
Min: 0.03  Med: 0.10 Max: 0.52
Current: 0.03
0.03
0.52
Dividend Payout 0.01
COO's Dividend Payout is ranked higher than
99% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.36 vs. COO: 0.01 )
Ranked among companies with meaningful Dividend Payout only.
COO' s 10-Year Dividend Payout Range
Min: 0.02  Med: 0.05 Max: 0.25
Current: 0.01
0.02
0.25
Yield on cost (5-Year) 0.03
COO's Yield on cost (5-Year) is ranked lower than
99% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.65 vs. COO: 0.03 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
COO' s 10-Year Yield on cost (5-Year) Range
Min: 0.03  Med: 0.10 Max: 0.52
Current: 0.03
0.03
0.52
Share Buyback Rate -0.40
COO's Share Buyback Rate is ranked higher than
68% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. COO: -0.40 )
Ranked among companies with meaningful Share Buyback Rate only.
COO' s 10-Year Share Buyback Rate Range
Min: 1.5  Med: -2.90 Max: -13
Current: -0.4

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 411.98
COO's Price/Tangible Book is ranked lower than
100% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.31 vs. COO: 411.98 )
Ranked among companies with meaningful Price/Tangible Book only.
COO' s 10-Year Price/Tangible Book Range
Min: 3.28  Med: 8.15 Max: 1473.33
Current: 411.98
3.28
1473.33
Price/Projected FCF 1.76
COO's Price/Projected FCF is ranked higher than
57% of the 79 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. COO: 1.76 )
Ranked among companies with meaningful Price/Projected FCF only.
COO' s 10-Year Price/Projected FCF Range
Min: 0.55  Med: 1.64 Max: 5.86
Current: 1.76
0.55
5.86
Price/DCF (Earnings Based) 4.60
COO's Price/DCF (Earnings Based) is ranked lower than
89% of the 18 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. COO: 4.60 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.73
COO's Price/Median PS Value is ranked lower than
75% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.27 vs. COO: 1.73 )
Ranked among companies with meaningful Price/Median PS Value only.
COO' s 10-Year Price/Median PS Value Range
Min: 0.26  Med: 0.96 Max: 2.57
Current: 1.73
0.26
2.57
Price/Peter Lynch Fair Value 2.67
COO's Price/Peter Lynch Fair Value is ranked lower than
68% of the 41 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.98 vs. COO: 2.67 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
COO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.6  Med: 1.29 Max: 70
Current: 2.67
0.6
70
Price/Graham Number 25.49
COO's Price/Graham Number is ranked lower than
100% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. COO: 25.49 )
Ranked among companies with meaningful Price/Graham Number only.
COO' s 10-Year Price/Graham Number Range
Min: 0.74  Med: 2.59 Max: 49.66
Current: 25.49
0.74
49.66
Earnings Yield (Greenblatt) (%) 2.79
COO's Earnings Yield (Greenblatt) (%) is ranked lower than
51% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. COO: 2.79 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
COO' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.5  Med: 5.20 Max: 12.2
Current: 2.79
1.5
12.2
Forward Rate of Return (Yacktman) (%) 15.98
COO's Forward Rate of Return (Yacktman) (%) is ranked higher than
70% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.94 vs. COO: 15.98 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
COO' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -2.4  Med: 18.00 Max: 22.8
Current: 15.98
-2.4
22.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, ISRG » details
Traded in other countries:COO.Mexico, CP6.Germany,
Cooper Companies is a Delaware corporation, which was organized on March 4, 1980. It is a medical device company. Through its subsidiaries, it manufactures products for contact lens wearers and supplies women's health clinicians with products and treatment options to improve the delivery of healthcare to women. It develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. It products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness; with a broad collection of spherical, toric and multifocal contact lenses. The Company's customers are healthcare professionals and institutions providing care to and for women. Its products support the point of healthcare delivery in the hospital, clinician's office and fertility clinics. The Company's major manufacturing and distribution facilities are located in Trumbull, Connecticut, Malov, Denmark, Pasadena, California, Stafford, Texas, and Berlin, Germany. The Company's products are medical devices subject to extensive regulation by the United States Food and Drug Administration (FDA) in the United States and other regulatory bodies abroad. The Company's raw materials primarily consist of various chemicals and packaging materials and are generally available from more than one source. It markets its products in the United States through field sales representatives, who call on optometrists, ophthalmologists, opticians, optical chains and distributors.
» More Articles for COO

Headlines

Articles On GuruFocus.com
Steve Mandel Buys Visa, DaVita Healthcare In Q4 Feb 19 2015 
CooperVision MyDay(R) Daily Disposable Lenses Now Available in Hong Kong Jan 04 2015 
Offsetters Helps Vancity Credit Union Achieve Carbon Neutrality for 6th Consecutive Year Dec 19 2014 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Offsetters Climate Solutions Inc.: British Columbia Government Establishes New Regulated Carbon Offs Oct 23 2014 
Weekly CEO Sells Highlight: Cooper Companies, Broadcom Corp, Realpage Inc, and Freescale Semiconduct Jul 14 2014 
Baron Funds Comments on The Cooper Companies May 02 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Manning & Napier New Buys of Q1 Apr 19 2013 
The Cooper Companies: Not Eyeing It Yet Nov 27 2012 

More From Other Websites
The Cooper Companies Declares Cash Dividend Jul 09 2015
The Cooper Companies Declares Cash Dividend Jul 09 2015
Slight bubble, but not like the past: Pro Jun 26 2015
COOPER COMPANIES INC Financials Jun 11 2015
COOPER COMPANIES INC Files SEC form 10-Q, Quarterly Report Jun 05 2015
Cooper Companies Lags Q2 Earnings, Revenues, View Slashed - Analyst Blog Jun 05 2015
Anthera Pharmaceuticals, Aeropostale, Adobe Lead Thursday's After-Hours Movers Jun 04 2015
Cooper Companies Inc Earnings Call scheduled for 5:00 pm ET today Jun 04 2015
The Cooper Companies Announces Second Quarter 2015 Results Jun 04 2015
COOPER COMPANIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jun 04 2015
Cooper Cos. misses Street 2Q forecasts Jun 04 2015
The Cooper Companies Announces Second Quarter 2015 Results Jun 04 2015
Q2 2015 Cooper Companies Inc Earnings Release - 4:00 pm ET Jun 04 2015
Wild week ahead as traders watch for June swoon May 29 2015
The Cooper Companies to Present at William Blair Conference May 27 2015
The Cooper Companies to Present at William Blair Conference May 27 2015
The Cooper Companies Announces Release Date for Second Quarter 2015 May 05 2015
The Cooper Companies Announces Release Date for Second Quarter 2015 May 05 2015
Receptos Inc (RCPT), Centene Corp (CNC): Paul Sinclair Flying High With New Fund’s Top Healthcare... Apr 14 2015
Lone Pine Adds New Stake in The Cooper Companies Apr 14 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK